Skip to main content

View full-text article in PMC

. 2023 Nov 7;28:490. doi: 10.1186/s40001-023-01388-w

Table 4.

Univariate and multivariable analyses of survival factors in patients with HCC

	Univariate analysis				Multivariate analysis
	HR	P >\|z\|	95% CI		HR	P >\|z\|	95% CI
TMEM79 expression
High vs low or none	4.552	< 0.001^a	3.047	6.801	3.833	< 0.001^a	2.520	5.831
SMG5 expression
High vs low or none	2.945	< 0.001^a	1.984	4.372	1.903	0.002^a	1.257	2.883
Age (years)
≤ 60 vs > 60	1.001	0.995	0.694	1.444
Gender
Male vs female	1.183	0.373	0.818	1.712
Tumor diameter (cm)
≤ 3 vs > 3	1.482	0.015^a	1.079	2.037	1.446	0.039^a	1.019	2.051
AFP (μg/L)
≤ 400 vs > 400	1.091	0.644	0.754	1.579
Tumor number
Solitary vs multiple	0.491	0.001^a	0.328	0.737	0.976	0.927	0.578	1.647
TNM stage
I vs II vs III + IV	1.878	< 0.001^a	1.612	2.187	1.487	0.119	0.904	2.446
T
1 vs 2 vs 3 vs 4	2.274	< 0.001^a	1.839	2.813	1.338	0.179	0.875	2.044
N
0 vs 1	2.005	0.126	0.822	4.895
M
0 vs 1	4.278	< 0.001^a	2.590	7.066	0.910	0.852	0.338	2.451
Differentiation
Well vs moderate vs poor	1.211	0.146	0.936	1.566
Hepatitis B virus infection
No vs yes	0.762	0.384	0.412	1.406
Vascular invasion
No vs yes	1.763	0.003^a	1.209	2.571	0.351	0.318	0.045	2.734
Liver Cirrhosis
No vs yes	0.945	0.723	0.689	1.294
Recurrence
No vs yes	1.812	0.002^a	1.247	2.633	1.968	0.508	0.265	14.638

HCC hepatocellular carcinoma, HR hazard ratio, CI confidence interval

^aP < 0.05 was considered significant